RSV IMMUNISATION
Clinical trials for RSV IMMUNISATION explained in plain language.
Never miss a new study
Get alerted when new RSV IMMUNISATION trials appear
Sign up with your email to follow new studies for RSV IMMUNISATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Nasal spray vaccine trial aims to shield babies from RSV
⭐️ VACCINE ⭐️ TerminatedThis large study tested a new nasal spray vaccine designed to protect infants and toddlers from Respiratory Syncytial Virus (RSV), a common cause of serious lung infections. About 6,300 healthy children, aged 6 months to under 2 years, received either the vaccine or a placebo spr…
Matched conditions: RSV IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:39 UTC
-
New nasal spray vaccine tested to protect babies from RSV
⭐️ VACCINE ⭐️ TerminatedThis study tested a new nasal spray vaccine designed to protect infants and toddlers from Respiratory Syncytial Virus (RSV), a common cause of severe lung infections in young children. It involved about 950 healthy children aged 6 months to under 2 years old. The main goals were …
Matched conditions: RSV IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 05, 2026 14:00 UTC